Hem › Övervikt › Missouri › Kansas City
Kliniska studier för Övervikt i Kansas City, MO
11 studier för Övervikt söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekryterarFas 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekryterarFas 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekryterarFas 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekryterarFas 3
- Research Site, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekryterarFas 3
- Research Site, Kansas City
- Research Site, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekryterarFas 3
- Saint Luke's Hospital of Kansas City, Kansas City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RekryterarFas 3
- Kansas City VA Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
RekryterarFas 3
- Research Site, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekryterarFas 3
- Clinical Research Consultants, JCCT Co, Kansas City
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
RekryterarFas 1
- MBX Biosciences Investigational Site, Kansas City
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
RekryterarFas 2Friska volontärer välkomna
- University Health, Kansas City
- University of Missouri-Kansas City, Kansas City
Övervikt-studier i andra städer
- Houston, TX42 studier
- Chicago, IL40 studier
- San Antonio, TX39 studier
- New York City, NY39 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA27 studier
- Miami, FL26 studier
- Jacksonville, FL25 studier
- St. Louis, MO25 studier
- Baltimore, MD25 studier
Andra studier i Kansas City
- Bröstcancer34 studier
- Icke-småcellig lungcancer31 studier
- Hjärtsvikt25 studier
- Cancer (alla typer)22 studier
- Lungcancer19 studier
- Kolorektal cancer16 studier
- Metastaserande cancer15 studier
- Akut myeloid leukemi15 studier
- Prostatacancer14 studier
- Äggstockscancer12 studier
- Typ 2-diabetes11 studier
- Hjärt-kärlsjukdom11 studier
Från ClinicalTrials.gov, data hämtad 7 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.